cover
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
respirasi@journal.unair.ac.id
Editorial Address
Jl. Mayjen Prof. Dr. Moestopo 6-8 Surabaya 60286 Indonesia
Location
Kota surabaya,
Jawa timur
INDONESIA
Jurnal Respirasi (JR)
Published by Universitas Airlangga
ISSN : 24070831     EISSN : 26218372     DOI : -
Core Subject : Health,
Jurnal Respirasi is a National journal in accreditation process managed by Department of Pulmonology & Respiratory Medicine Faculty of Medicine Airlangga University - Dr. Soetomo General Hospital, Surabaya. Publish every January, May, September every year with each of 5 (five) complete texts in Indonesian.
Arjuna Subject : -
Articles 7 Documents
Search results for , issue "Vol. 3 No. 3 (2017): September 2017" : 7 Documents clear
Seorang Wanita dengan Pneumokoniosis yang Mengalami Komplikasi Trapped Lung dan Dilakukan Dekortikasi: [Decortication of Trapped Lung in Pneumoconiosis Patient: A Case Report] Tutik Kusmiati; Winariani Koesoemoprodjo; Novita Maulidiyah
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1076.4 KB) | DOI: 10.20473/jr.v3-I.3.2017.74-80

Abstract

Background: Pneumoconiosis is an occupational lung disease caused by dust inhalation which deposit in lung parenchym and cause lung fibrosis. Trapped lung is impairment of compliance because of pleural inflammation. Case: We presented a diagnostic problem case of a woman, 37 years old who worked at coffee factory for 20 years as a coffee powder packer. Patient came in previous hospital with continous dispnea not relieved by rest or medication. She had been diagnosed with pneumothorax and already treated with chest tube for 2 weeks but there was no improvement. Patient was reffered to Dr. Soetomo hospital and treated with continous suction and chest physiotherapy for 2 months but there was no improvement. Patient then underwent thoracoscopy to find the cause of persistent collapsed lung. Thoracoscopy showed blackish leucoplaque pleural biopsy was done histopathological result showed pneumoconiosis. CT Scan showed fluidopneumothorax and severe lung restriction. The patient then underwent torachotomy and decortication which showed attachment of medial, inferior, and posterior lobe of left lung and organized pleural effusion. Post operation, the lung expanded completely and patient condition improved. Conclusion: Lung entrampment rarely become the complication of pneumoconiosis. Early diagnosis and appropriate treatment will avoid further complication.
Sidero-Siliko Tuberkulosis pada Penderita Efusi Pleura Masif Dekstra yang Awalnya Dicurigai Keganasan: [Malignant Suspicion of Massive Pleural Effusion in Sidero-Silico Tuberculosis Patient] Winariani Koesoemoprodjo; Hapsari Paramita Narendrani
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (726.238 KB) | DOI: 10.20473/jr.v3-I.3.2017.81-88

Abstract

Background: Pneumoconiosis defined as the accumulation of dust in the lungs and causes tissue reactions to mineral materials from various industries that affect the respiratory system. Among the causes of pneumoconiosis are silica dust (silicosis) and iron dust (ciderosis). Pneumoconiosis provides a pathological reaction in lung tissue due to inhaled deposition of mineral particulate dust or persistent fiber material. The risk of infection with tuberculosis is higher in patients with pneumoconiosis, especially silicosis. Most cases of pleural effusion are found in malignancies or infections such as tuberculosis but can also be a complication of pneumoconiosis. Case: A man, 55 years old, reported with a 2-week congested complaint that was getting worse, with a cough for almost 1 month. Patients with work history as iron lathers for 25 years with comorbid diabetes mellitus. From the results of our chest x-rays we get a picture of massive pleural effusion with a total evacuation of approximately 9 liters, whereas on the chest CT scan get a solid mass picture in the right lung field with multiple nodules in the liver. The results of bronkoalveolar rinses obtained silica and iron content, and obtained Mycobacterium tuberculosis culture in pleural fluid culture. Conclusion: Illustration of a case report of a 55-year-old man diagnosed as a sidero-silico-tuberculosis with a periodic picture of tuberculosis and pleural effusion in the right lung undergoing resolution with OAT treatment.
Faal Paru Dinamis: [Dynamic Lung Function] Arief Bakhtiar; Renny Irviana Eka Tantri
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (593.92 KB) | DOI: 10.20473/jr.v3-I.3.2017.89-96

Abstract

Pulmonary function is an examination to measure lung volume function using spirometry. Tests with spirometry to detect abnormalities associated with respiratory distress. Spirometry examination is not only to determine the diagnosis but also to assess the severity of obstruction, restriction, and the effects of treatment. Spirometry examination is a test to measure the volume of a person’s static and dynamic lungs with a spirometer tool. Dynamic lung spirometry consists of Forced vital capacity (FVC), Forced expiratory volume (FEVT), Forced expiratory flow200-1200 / FEF 200-1200, Forced expiratory flow25% -75% / FEF 25% -75%, Peak expiratory flow rate / PEFR, Maximum voluntary ventilation / MVV / MBC, FEV1 / FVC Ratio. Ventilation disorders consist of: restriction and obstruction disorders. Restriction is a disorder of lung development by any cause. In obstruction disorder, it shows a decrease in velocity of expiratory flow and normal vital capacity. FEV values, which are widely used are FEV1 / FVC, abnormal when <80%, FEV1 / FVC ratio <80%. This parameter is very important because the accuracy level for obstruction in the central airway is quite large. In obstructive disorder there is generally a decrease in pulmonary dynamic volume. Significant parameters are FEV 1 / FVC, PEFR, and FEF 25-75. The FEV1 / FVC ratio is important because the accuracy level for obstruction in the central airway is considerable, whereas FEF 25-75 indicates obstruction in the small airway.
Back Matter Vol 3 No 3, 2017 Back Matter
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (184.282 KB) | DOI: 10.20473/jr.v3-I.3.2017.%p

Abstract

Characteristics and the Side Effects of New MDR-TB Treatment in the Dr. Soetomo Hospital during 2016 Umi Fatmawati; Tutik Kusmiati
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (248.849 KB) | DOI: 10.20473/jr.v3-I.3.2017.67-73

Abstract

Background: The Multi Drug Resistance Tuberculosis (MDR-TB) prevalence rate is by 6900 in which there are 1.9% of new cases and 12 % of cases fail. Indonesia ranks eighth out of 27 countries in the world. This study is aimed to investigate the characteristics of the new MDR TB patient demographic data, treatment, and side effects. Method: This research was analyzed retrospective data of the Medical Record (MR). Data were analyzed qualitatively. Results: The number of new patients are 82 people consisting of 41 men and 41 women. About 35 patients came from Surabaya and 47 were from outside Surabaya. Among those, 28 patients are 51–60 years old. Patients in the intensive phase (0–8 month) were 47 patient and 35 patients were in the continue phase 9–24 month. The main cause is the highest MDR-TB relapse 33 patients. Cycloserin and ethionamide prescribed to all of the subject followed by levofloxacin which is prescribed to 68 patients. The other medication were kanamycin, capreomycon, moxifloxacin and Para Amino Salicylat (PAS) which administered to 27,14,7 patient consecutively. Nausea is the one of the Adverse Drug reaction (ADR) that is preverly emerged. There were 30 patients complary this ADR and treatment which Omeprazole and Ranitidin. Conclusion: Characteristics of patients greatly differed between patients categories. In Soetomo hospital effort should be made to improve management case, drug and prevent or eliminate adverse drug reaction.
Front Matter Vol 3 No 3, 2017 Front Matter
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (136.701 KB) | DOI: 10.20473/jr.v3-I.3.2017.%p

Abstract

Pendekatan Terapi Asthma-COPD Overlap (ACO): [The Approach of Asthma-COPD Overlap Syndrome Treatment] Muhammad Amin; Alamsyah Sitepu
Jurnal Respirasi Vol. 3 No. 3 (2017): September 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1458.147 KB) | DOI: 10.20473/jr.v3-I.3.2017.97-105

Abstract

Asthma and COPD are the most common chronic airways disease and have different clinical manifestations and treatments. Asthma is an airway inflammatory disease mediated by Th2 cytokines, CD4 + lymphocytes and eosinophils, whereas inflammation of COPD is affected by Th1 cytokines, CD8 + lymphocytes and neutrophils. Asthma-COPD overlap (ACO) is the presence of persistent airflow limitations with some symptoms resembling asthma and some other symptoms similar to COPD. Current treatment of ACO is to target the dominant inflammatory phenotype of eosinophils and neutrophils. Treatments given to patients with dominant eosinophil phenotype are inhaled and anti-IgE corticosteroids, and the drugs under reasearch are anti-IL-5, anti-IL-13, GATA3 inhibitors, anti-IL-33, anti-IL-25 and anti-thymic stromal lymphopoietin (anti-TSLP). Treatment given to patients with dominant neutrophil phenotype was macrolide, and treatment under reasearch was anti-IL-1, anti-IL-17A, anti-IL-23, CXCR2 antagonists, p38 MAPK inhibitor / JAK inhibitors and PDE4 inhibitors. Paucygranulocyte patient were given LAMA, LAMA + LABA therapy and bronchial thermoplasty. The therapy currently under study for this group is triple inhalation.

Page 1 of 1 | Total Record : 7